Haemonetics (HAE) reported $321.39 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 4.4%. EPS of $1.10 for the same period compares to $1.02 a year ago.The reported revenue represents a surprise of +5.97% over the Zacks Consensus Estimate of $303.28 million. With the consensus EPS estimate being $1.01, the EPS surprise was +8.91%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine t ...